This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic

Name: This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
License: Public Domain

GlaxoSmithKline

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hypereosinophilic syndrome, mepo, hes, compassionate use, mepolizumab, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 913672
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.